Cullinan Oncology, Inc. (CGEM) Tops Q1 EPS by 8c
Tweet
Share
E-mailGet Alerts CGEM Hot Sheet
Join SI Premium – FREE
Cullinan Oncology, Inc. (NASDAQ: CGEM) reported Q1 EPS of ($0.75), $0.08 better than the analyst estimate of ($0.83).
For earnings history and earnings-related data on Cullinan Oncology, Inc. (CGEM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Barclays Starts Hawkins (HWKN) at Equalweight
- Canaccord Starts Regal Partners Ltd (RPL:AU) at Buy
- Evercore ISI Upgrades Owens Corning (OC) to Outperform
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
